Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    CAFQ056A2217
Show Display Options
Rank Status Study
1 Completed Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Parkinson Disease;   Dyskinesia, Drug-Induced;   Levodopa
Intervention: Drug: AFQ056

Indicates status has not been verified in more than two years